Showing results (2141-2150 of 5,493) with videos related to
Sort By:
Pageof 550
Pharmacotherapy|October 5, 2024
Intravenous ketamine successfully treats treatment-resistant catatonia in schizophrenia: A case reportAtif SiddiquiPharmacotherapy|October 9, 2024
Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi-site retrospective studyMaria-Stephanie A Hughes, Tiffany Lee, Jonathan D Faldasz, et al.Pharmacotherapy|October 9, 2024
Albuminuria-based stratification of end-stage kidney disease progression and mortality with sodium-glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney diseaseTien-Jyun Chang, Yen-Chieh Lee, Li-Chiu Wu, et al.Pharmacotherapy|October 14, 2024
Association between gastroprotective agents and acute kidney injury in patients receiving non-steroidal anti-inflammatory drugs: Analysis of a Japanese hospital-based databaseSatoru Mitsuboshi, Shungo Imai, Hayato Kizaki, et al.Pharmacotherapy|September 25, 2024
Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta-analysisPaweł Moćko, Magdalena Koperny, Katarzyna Śladowska, et al.Pharmacotherapy|February 21, 2025
The potential role of GLP-1 receptor agonists in osteoarthritisMackenzie Ryan, Saige Megyeri, Wes Nuffer, et al.Pharmacotherapy|July 30, 2024
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infectionsKatie B Olney, Manjunath P Pai, Jenni K Thomas, et al.Pharmacotherapy|June 26, 2024
Thirty-day risk of digoxin toxicity among older adults co-prescribed trimethoprim-sulfamethoxazole versus amoxicillin: A population-based cohort studyFlory T Muanda, Matthew A Weir, Fatemeh Ahmadi, et al.Pharmacotherapy|April 28, 2006
New and emerging strategies for reducing cardiometabolic risk factorsPhilip T Rodgers, Dawn C FukePharmacotherapy|April 28, 2006
Evaluating and treating cardiometabolic risk factors: a case discussionStuart T Haines, Dawn C Fuke, Dan Lender, et al.Pageof 550